PGR and breast carcinoma: To identify targets of progesterone independent of PR status of cells, we set out to perform an integrated genomic profiling of a panel of PR-positive and PR-negative breast cancer cell lines treated with progesterone, followed by functional analysis of the components found to be significantly altered.